{
  "type": "hyp",
  "text": "LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha. LMP-1 an Epstein-Barr virus membrane protein expressed during latent infection has oncogenic properties as judged from its ability to transform B lymphocytes and rodent fibroblasts.\n",
  "self": {
    "NER": {
      "answers": [
        "Epstein-Barr"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What virus is LMP-1 expressed in?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "LMP-1",
        "NF-kappa B",
        "the inhibitory molecule",
        "I kappa B alpha",
        "an Epstein-Barr virus membrane protein",
        "latent infection",
        "oncogenic properties",
        "its ability",
        "B lymphocytes",
        "rodent fibroblasts"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What Epstein-Barr virus membrane protein is expressed during latent infection?",
          "What does LMP-1 activate?",
          "What does LMP-1 target?",
          "What molecule does LMP-1 target?",
          "What is LMP-1?",
          "When is LMP-1 expressed?",
          "What is the ability of LMP-1 to transform B lymphocytes and rodent fibro",
          "What is the oncogenic properties of LMP-1?",
          "What does LMP-1 transform?",
          "What does LMP-1 transform?"
        ]
      }
    }
  },
  "asked": {
    "What virus is LMP-1 expressed in?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Epstein-Barr",
        "answerability": 0.9670962691307068,
        "ground_truth": {
          "Epstein-Barr": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What Epstein-Barr virus membrane protein is expressed during latent infection?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "LMP-1",
        "answerability": 0.9893719553947449,
        "ground_truth": {
          "LMP-1": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What does LMP-1 activate?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "NF-kappa B",
        "answerability": 0.9700971841812134,
        "ground_truth": {
          "NF-kappa B": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What does LMP-1 target?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.5827968120574951,
        "ground_truth": {
          "the inhibitory molecule": {
            "bertscore": 0.6363728046417236,
            "f1": 0
          }
        }
      }
    },
    "What molecule does LMP-1 target?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "I kappa B alpha",
        "answerability": 0.9175410270690918,
        "ground_truth": {
          "I kappa B alpha": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What is LMP-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "an Epstein-Barr virus membrane protein",
        "answerability": 0.9866426587104797,
        "ground_truth": {
          "an Epstein-Barr virus membrane protein": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "When is LMP-1 expressed?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "during latent infection",
        "answerability": 0.9793670177459717,
        "ground_truth": {
          "latent infection": {
            "bertscore": 0.8803805112838745,
            "f1": 0.8
          }
        }
      }
    },
    "What is the ability of LMP-1 to transform B lymphocytes and rodent fibro": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "oncogenic properties",
        "answerability": 0.9211312532424927,
        "ground_truth": {
          "oncogenic properties": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What is the oncogenic properties of LMP-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "transform B lymphocytes and rodent fibroblasts",
        "answerability": 0.980200469493866,
        "ground_truth": {
          "its ability": {
            "bertscore": 0.6311931610107422,
            "f1": 0
          }
        }
      }
    },
    "What does LMP-1 transform?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "B lymphocytes and rodent fibroblasts",
        "answerability": 0.9616866111755371,
        "ground_truth": {
          "B lymphocytes": {
            "bertscore": 0.8886091709136963,
            "f1": 0.5714285714285715
          },
          "rodent fibroblasts": {
            "bertscore": 0.847212016582489,
            "f1": 0.5714285714285715
          }
        }
      }
    }
  }
}